Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CorMedix Inc (NYSE American:CRMD)

0.609
Delayed Data
As of Oct 20
 +0.009 / +1.50%
Today’s Change
0.32
Today|||52-Week Range
2.48
-60.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$37.2M

Company Description

CorMedix, Inc. operates as pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Bridgewater, NJ.

Contact Information

CorMedix, Inc.
400 Connell Drive
Berkeley Heights New Jersey 07921
P:(908) 517-9500
Investor Relations:

Employees

Shareholders

Individual stakeholders8.75%
Other institutional22.00%
Mutual fund holders2.91%

Top Executives

Mohammed Khoso BaluchChief Executive Officer & Director
Bob CookChief Financial Officer
Antony E. PfaffleSecretary, Chief Scientific Officer & Director
John L. ArmstrongExecutive Vice President-Technical Operations
John OrtizVP-Regulatory Affairs & Quality Assurance